Timing is everything: intraperitoneal chemotherapy after primary or interval debulking surgery for advanced ovarian cancer.

Jessica LeeJohn P CurtinFranco M MuggiaBhavana PothuriLeslie R BoydStephanie V Blank

Published in: Cancer chemotherapy and pharmacology (2018)

Although IP chemotherapy after PDS is associated with improved survival, IP therapy after NACT and IDS, despite high rates of completion, may not have the same degree of survival advantage over IV therapy.

Keyphrases

minimally invasive
locally advanced
free survival
squamous cell carcinoma
radiation therapy
bone marrow
mesenchymal stem cells
cell therapy